Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Interferons and Epigallocatechin Gallate

Research Papers that Mention the Interaction

EGCG down-regulated VEGFC/VEGFR2 signaling through c-JUN, interferon-γ , matrix metalloproteinase 9, and chemokine (C-X-C motif) ligand 3 pathways for endothelial proliferation, inflammatory response, and mobility.
Fertility and sterility  •  2011  |  View Paper
Our data suggest that EGCG could impart therapeutic advantage if used in conjunction with IFN.
This study was undertaken to determine if EGCG could enhance the anti-proliferative effects of IFN.
Cell cycle  •  2009  |  View Paper
They demonstrated that melanoma growth was more efficiently inhibited by a combined treatment of EGCG and IFN than treated with either reagent alone.
Cell cycle  •  2009  |  View Paper
Epigallocatechin-3-gallate (EGCG) specifically inhibits IFN-γ pathways and unlike Janus Kinase 1 and 2 (JAK1/JAK2) inhibitors (tofacitinib, ruxolitinib), EGCG is safer, more cost-effective, and is a topically active agent.
However, CD8+ cells with positive Natural killer group 2 member D (NKG2D) transmembrane receptor (CD8+ … were treated with 20 μm EGCG for 48 h. Conclusion: These results suggest that EGCG has a synergistic action that … HLA-B molecules via the IFN-γ pathway to maintain immune … CD8+ NKG2D+ subset.
International journal of environmental research and public health  •  2018  |  View Paper
In primary cultured human melanocytes, EGCG pre-treatment attenuated interferon (IFN)-γ-induced phosphorylation of JAK2 and its downstream signal transducer and activator of transcription (STAT)1 and STAT3 in a dose-dependent manner.
Biological & pharmaceutical bulletin  •  2015  |  View Paper
The results showed that the JAK/STAT pathway activation by proinflammatory cytokine interleukin‐6 and interferon‐γ in CCA cells was suppressed by pretreatment with quercetin and EGCG , evidently by a decrease of the elevated phosphorylated‐STAT1 and STAT3 proteins in a dose‐dependent manner.
Phytotherapy research : PTR  •  2014  |  View Paper
4 Treatment with IFN‐γ activated phospho‐p38 MAPK, this effect being detected … as 1 h, persisting over 3 h and decreasing after 24 h. IFN‐γ produced a sustained action of …‐STAT1 that was prevented by EGCG and partially attenuated by SB 203580 … insensitive to downregulation of PKC.
British journal of pharmacology  •  2005  |  View Paper
In addition, EGCG treatment decreased the circulat-ing tumour necrosis factor-α, interleukin-6, monocyte chemoattractant protein-1, and interferon-γ levels in apolipoprotein E-deficient mice.
Kardiologia polska  •  2018  |  View Paper
We further showed that EGCG reduced production of interferon-γ , IL-17, IL-6, IL-1β, and tumor necrosis factor-α; decreased types 1 and 17 helper T cells (Th1 and Th17, respectively); and increased regulatory T-cell populations in lymph nodes, the spleen, and the central nervous system.
The American journal of pathology  •  2012  |  View Paper
Treatment with EGCG significantly reduced interleukin-1β, interferon-γ (INF-γ) and tumor necrosis factor-α (TNF-α) levels in the AIT rats through suppression of nuclear factor-κB (NF-κB) pathway.
Experimental and therapeutic medicine  •  2018  |  View Paper